Literature DB >> 18052117

Design and synthesis of human immunodeficiency virus entry inhibitors: sulfonamide as an isostere for the alpha-ketoamide group.

Rong-Jian Lu1, John A Tucker, Tatiana Zinevitch, Olga Kirichenko, Vitalii Konoplev, Svetlana Kuznetsova, Sergey Sviridov, Jason Pickens, Sagun Tandel, Enugurthi Brahmachary, Yang Yang, Jian Wang, Stephanie Freel, Shelly Fisher, Alana Sullivan, Jiying Zhou, Sherry Stanfield-Oakley, Michael Greenberg, Dani Bolognesi, Brian Bray, Barney Koszalka, Peter Jeffs, Alisher Khasanov, You-An Ma, Cynthia Jeffries, Changhui Liu, Tatiana Proskurina, Tong Zhu, Alexander Chucholowski, Rongshi Li, Connie Sexton.   

Abstract

The crystal structures of many tertiary alpha-ketoamides reveal an orthogonal arrangement of the two carbonyl groups. Based on the hypothesis that the alpha-ketoamide HIV attachment inhibitor BMS 806 (formally BMS378806, 26) might bind to its gp120 target via a similar conformation, we designed and synthesized a series of analogs in which the ketoamide group is replaced by an isosteric sulfonamide group. The most potent of these analogs, 14i, demonstrated antiviral potency comparable to 26 in the M33 pseudotyped antiviral assay. Flexible overlay calculations of a ketoamide inhibitor with a sulfonamide inhibitor revealed a single conformation of each that gave significantly better overlap of key pharmacophore features than other conformations and thus suggest a possible binding conformation for each class.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18052117     DOI: 10.1021/jm070650e

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  10 in total

1.  Theoretical studies on sulfanilamide and derivatives with antibacterial activity: conformational and electronic analysis.

Authors:  Esteban G Vega-Hissi; Matías F Andrada; Graciela N Zamarbide; Mario R Estrada; Francisco Tomás-Vert
Journal:  J Mol Model       Date:  2010-09-07       Impact factor: 1.810

2.  Discovery of entry inhibitors for HIV-1 via a new de novo protein design framework.

Authors:  M L Bellows; M S Taylor; P A Cole; L Shen; R F Siliciano; H K Fung; C A Floudas
Journal:  Biophys J       Date:  2010-11-17       Impact factor: 4.033

Review 3.  Computational methods for de novo protein design and its applications to the human immunodeficiency virus 1, purine nucleoside phosphorylase, ubiquitin specific protease 7, and histone demethylases.

Authors:  M L Bellows; C A Floudas
Journal:  Curr Drug Targets       Date:  2010-03       Impact factor: 3.465

4.  General method for synthesis of 2-heterocyclic N-methyliminodiacetic acid boronates.

Authors:  Graham R Dick; David M Knapp; Eric P Gillis; Martin D Burke
Journal:  Org Lett       Date:  2010-05-21       Impact factor: 6.005

Review 5.  The Genesis and Future Prospects of Small Molecule HIV-1 Attachment Inhibitors.

Authors:  Tao Wang; John F Kadow; Nicholas A Meanwell; Mark Krystal
Journal:  Adv Exp Med Biol       Date:  2022       Impact factor: 2.622

6.  Combination potentiator ('co-potentiator') therapy for CF caused by CFTR mutants, including N1303K, that are poorly responsive to single potentiators.

Authors:  Puay-Wah Phuan; Jung-Ho Son; Joseph-Anthony Tan; Clarabella Li; Ilaria Musante; Lorna Zlock; Dennis W Nielson; Walter E Finkbeiner; Mark J Kurth; Luis J Galietta; Peter M Haggie; Alan S Verkman
Journal:  J Cyst Fibros       Date:  2018-06-12       Impact factor: 5.482

7.  Computational design, synthesis and evaluation of new sulphonamide derivatives targeting HIV-1 gp120.

Authors:  Radhika Vangala; Sree Kanth Sivan; Saikiran Reddy Peddi; Vijjulatha Manga
Journal:  J Comput Aided Mol Des       Date:  2019-12-02       Impact factor: 3.686

Review 8.  Discovery and Development of Anti-HIV Therapeutic Agents: Progress Towards Improved HIV Medication.

Authors:  Kenji Maeda; Debananda Das; Takuya Kobayakawa; Hirokazu Tamamura; Hiroaki Takeuchi
Journal:  Curr Top Med Chem       Date:  2019       Impact factor: 3.295

9.  N-(2-Amino-5-chloro-phen-yl)-2-bromo-benzene-sulfonamide.

Authors:  Maria Altamura; Valentina Fedi; Rossano Nannicini; Paola Paoli; Patrizia Rossi
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2012-11-10

10.  N,N-Diethyl-2-(4-methyl-benzene-sulfonamido)-benzamide.

Authors:  Maria Altamura; Valentina Fedi; Rossano Nannicini; Paola Paoli; Patrizia Rossi
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2012-10-20
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.